Skip to content

HIMS & HERS HEALTH, INC.: 10-Q filed 2020-11-13

What HIMS & HERS HEALTH, INC. reported in its quarterly report filed 2020-11-13 (fiscal Q3 2020): 18 published measures, 52 facts as tagged in accession 0001193125-20-291907.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-13
Fiscal period
fiscal Q3 2020
Accession
0001193125-20-291907 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HIMS & HERS HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-30205,813,988USD
At 2019-12-31204,765,183USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-3010,231,475USD
At 2019-12-318,173,144USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-305,000,003USD
At 2020-06-305,000,005USD
At 2020-03-315,000,001USD
At 2019-12-315,000,009USD
At 2019-09-305,000,006USD
At 2019-06-308,394USD
At 2019-04-080USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-301,257,601USD
At 2019-12-311,510,341USD
At 2019-09-301,781,500USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,256,772USD92
2020-01-01 to 2020-09-30-1,009,526USD274
2020-04-01 to 2020-06-30-86,776USD91
2020-01-01 to 2020-03-311,334,022USD91
2019-07-01 to 2019-09-30436,045USD92
2019-04-09 to 2019-09-30419,439USD175
2019-04-09 to 2019-06-30-16,606USD83

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-577,740USD274
2019-04-09 to 2019-09-30-207,200USD175

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-04-09 to 2019-09-30203,238,700USD175

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30325,000USD274
2019-04-09 to 2019-09-30-201,250,000USD175

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30137,736USD
At 2019-12-311,147,262USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,338,004USD92
2020-01-01 to 2020-09-30-2,708,421USD274
2019-07-01 to 2019-09-30-449,938USD92
2019-04-09 to 2019-09-30-466,544USD175

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-301,332,751USD
At 2019-12-311,657,841USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-303,037,725USD
At 2019-12-31979,394USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-3024,713USD
At 2019-12-3118,475USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-304,861,657USD
At 2019-12-313,852,147USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-302,579,005USD
At 2019-12-31478,577USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,338,004USD92
2020-01-01 to 2020-09-302,708,421USD274
2019-07-01 to 2019-09-30449,938USD92
2019-04-09 to 2019-09-30466,544USD175

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-3081,232USD92
2020-01-01 to 2020-09-301,698,895USD274
2019-07-01 to 2019-09-30885,983USD92
2019-04-09 to 2019-09-30885,983USD175

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-30,126USD274
2019-04-09 to 2019-09-3050,655USD175

Inspect the source

Entity
HIMS & HERS HEALTH, INC. / CIK 0001773751
Captured
2026-09-21T17:30:19.175Z
SEC response SHA-256
e4951261793395e8ec3cfcd7f86bdd3ed6d36e381ab8a7158087efdfdc140d66

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001773751.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))